Key facts
- It has raised $4.5M across 5 recorded rounds; the latest was Seed Round ($951K) in Dec 2024.
- Notable investors include Runway Healthcare.
- Toetal Solutions has filed 9 Form Ds with the SEC since 2021, most recently Dec 2024 ($951K sold to 16 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Toetal Solutions
Funding rounds
5 roundsAbout Toetal Solutions
Developer of an ankle medical device designed to offer clinically effective treatment for foot and ankle deformities. The company's device uses a proprietary deployable nitinol implant that comes sterile and packed with all necessary disposable instrumentation to perform the procedure in any surgical setting, enabling foot and ankle surgeons to address rigid hammertoe deformities cost-effectively.
- Sector
- Healthcare
- HQ
- Malvern, PA, United States
- Founded
- 2021
- Employees
- 3
- Website
- toetal-solutions.com/
- Ownership
- Privately Held (backing)
Toetal Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Toetal Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Toetal Solutions in its N-PORT filings yet. We sweep new filings monthly.